Form 4 for STE Steris
Accepted 2021-10-05 00:00:00 ET · period of report 2021-10-01 · accession 0001209191-21-059554 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-05 | 2021-10-01 | STE | Zangerle John Adam | SVP, Gen Counsel, Sec | A - Grant | $0.00 | +808 | 31.0K | +3% | $0 |
| D | 2021-10-05 | 2021-10-01 | STE | Zangerle John Adam | SVP, Gen Counsel, Sec | A - Grant | $0.00 | +8,196 | 8,196 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2021-10-01 | A | A | 808 | $0.00 | 31,023 | D | — | — | (F1) All 808 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 202 on October 3, 2022; 202 on October 2, 2023; 202 on October 1, 2024 and 202 on October 1, 2025. (F2) 14,064 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,636 on May 31, 2022; 2,502 on May 31, 2022; 1,504 on June 1, 2022; 819 on June 2, 2022; 202 on October 3, 2022; 834 on May 31, 2023; 752 on June 1, 2023; 819 on June 2, 2023; 202 on October 2, 2023; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 819 on June 2, 2025; 202 on October 1, 2025. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2021-10-01 | A | A | 8,196 | $0.00 | 8,196 | D | $228.36 · — to 2031-10-01 | 8,196 Ordinary Shares | (F3) This option becomes exercisable as follows: 2,049 on October 3, 2022; 2,049 on October 2, 2023; 2,049 on October 1, 2024 and 2,049 on October 1, 2025. |